GRN and neoplasm: The univariate Cox’s regression analysis (Table 4) revealed that GP88 positivity was associated with a 1.9-fold, 2.5-fold and 1.7-fold increased risk of death (p = 0.003), tumor-related death (p = 0.021) and relapse occurrence (p = 0.043), respectively.